دورية أكاديمية

Research Progress on the Cardiovascular Protective Effect of Glucagon-Like Peptide-1 Receptor Agonists.

التفاصيل البيبلوغرافية
العنوان: Research Progress on the Cardiovascular Protective Effect of Glucagon-Like Peptide-1 Receptor Agonists.
المؤلفون: Song, Rui, Qian, Hang, Wang, Yunlian, Li, Qingmei, Li, Dongfeng, Chen, Jishun, Yang, Jingning, Zhong, Jixin, Yang, Handong, Min, Xinwen, Xu, Hao, Yang, Yong, Chen, Jun
المصدر: Journal of Diabetes Research; 4/8/2022, p1-8, 8p
مصطلحات موضوعية: GLUCAGON-like peptide-1 receptor, GLUCAGON-like peptide-1 agonists, CARDIOVASCULAR system, TYPE 2 diabetes, BLOOD sugar
مستخلص: The risk of cardiovascular diseases is closely related to diabetes. Macrovascular disease is the main cause of death and disability in patients with type 2 diabetes. In recent years, the glucagon-like peptide-1 receptor agonist (GLP-1RA), a new type of hypoglycemic drug, has been shown to regulate blood sugar levels, improve myocardial ischemia, regulate lipid metabolism, improve endothelial function, and exert a protective role in the cardiovascular system. This study reviewed the protective effects of GLP-1RA on the cardiovascular system. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Diabetes Research is the property of Hindawi Limited and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
قاعدة البيانات: Complementary Index
الوصف
تدمد:23146745
DOI:10.1155/2022/4554996